Skip to main content
. 2022 Feb 2;15:701–713. doi: 10.2147/JIR.S349996

Table 1.

Baseline Characteristics of the Study Population

Characteristics The Level of NPAR P value
<22.56 (n=980) 22.56–27.64 (n=980) >27.64 (n=982)
NPAR, dl/g 18.55 ± 4.19 25.03 ± 1.40 33.82 ± 6.40 <0.001
Clinical parameters
 Age, years 72.13 ± 13.95 72.99 ± 13.52 73.11 ± 14.13 0.237
 Gender, n(%) 0.420
  Male 520 (53.06) 497 (50.71) 494 (50.31)
  Female 460 (46.94) 483 (49.29) 488 (49.69)
 Ethnicity, n(%) <0.001
  White 687 (70.10) 712 (72.65) 724 (73.73)
  Black 153 (15.61) 107 (10.92) 88 (8.96)
  Other 140 (14.29) 161 (16.43) 170 (17.31)
Vital signs
 SBP, mmHg 118.54 ± 18.36 117.26 ± 17.13 113.45 ± 16.82 <0.001
 DBP, mmHg 60.11 ± 11.80 58.02 ± 10.17 55.95 ± 10.38 <0.001
 MAP, mmHg 77.31 ± 11.89 75.65 ± 10.49 73.38 ± 11.01 <0.001
 Heart rate, beats/minute 83.32 ± 16.61 84.45 ± 16.19 87.92 ± 16.11 <0.001
 RR, times/minute 19.79 ± 3.92 20.16 ± 4.07 20.34 ± 4.16 0.009
 Temperature, °C 36.75 ± 0.65 36.78 ± 0.67 36.74 ± 0.70 0.461
 SpO2, % 96.89 ± 2.07 96.77 ± 2.63 96.99 ± 2.83 0.170
Comorbidities, n(%)
 CHF 942 (96.12) 944 (96.33) 956 (97.35) 0.273
 Cardiac arrhythmias 526 (53.67) 571 (58.27) 559 (56.92) 0.109
 Infected 412 (42.04) 547 (55.82) 691 (70.37) <0.001
 Valvular disease 245 (25.00) 246 (25.10) 195 (19.86) 0.007
 Pulmonary circulation 134 (13.67) 137 (13.98) 109 (11.10) 0.113
 Chronic pulmonary 324 (33.06) 354 (36.12) 306 (31.16) 0.063
 Hypertension 636 (64.90) 634 (64.69) 528 (53.77) <0.001
 Renal failure 330 (33.67) 341 (34.80) 325 (33.10) 0.721
Laboratory parameters
 Albumin, g/dl 3.73 ± 0.48 3.31 ± 0.34 2.62 ± 0.41 <0.001
 Serum creatinine, mg/dl 2.14 ± 2.11 2.10 ± 1.91 2.10 ± 1.75 0.838
 Glucose, mg/dl 160.28 ± 93.25 168.67 ± 96.08 155.49 ± 98.02 0.009
 Serum urea nitrogen, mg/dl 38.63 ± 27.12 40.65 ± 27.80 44.10 ± 29.20 <0.001
 Hematocrit, % 35.18 ± 6.73 33.29 ± 6.57 31.49 ± 5.71 <0.001
 Hemoglobin, g/dl 11.66 ± 2.28 10.98 ± 2.23 10.30 ± 1.94 <0.001
 WBC, 109/l 11.90 ± 13.77 13.10 ± 7.37 15.25 ± 8.63 <0.001
 Neutrophil percentage, % 69.53 ± 17.54 82.78 ± 8.00 86.53 ± 6.97 <0.001
 Platelet, 109/l 234.15 ± 119.42 251.99 ± 118.31 266.00 ± 140.54 <0.001
 RDW, fl 15.50 ± 2.18 15.65 ± 2.18 16.26 ± 2.30 <0.001
 Sodium, mmol/l 137.87 ± 5.28 138.04 ± 5.44 138.36 ± 5.90 0.135
 Potassium, mmol/l 4.42 ± 0.88 4.38 ± 0.78 4.29 ± 0.78 0.002
 Bicarbonate, mmol/l 24.68 ± 5.83 24.20 ± 5.89 23.60 ± 5.90 <0.001
 Anion gap, mmol/l 16.92 ± 4.63 16.52 ± 4.50 15.78 ± 4.45 <0.001
 APTT, second 38.58 ± 25.17 38.91 ± 24.87 40.37 ± 25.11 0.256
 INR 1.76 ± 1.46 1.92 ± 1.94 1.87 ± 1.74 0.126
 PT, second 17.52 ± 9.58 18.74 ± 13.45 19.03 ± 15.55 0.029
Scoring systems
 SAPSII 40.07 ± 12.80 40.88 ± 11.57 45.41 ± 14.03 <0.001
 APSIII 49.55 ± 18.08 50.97 ± 16.63 59.91 ± 20.80 <0.001
In-hospital management, n(%)
 Vasopressin use 336 (34.29) 368 (37.55) 470 (47.86) <0.001
 RRT 71 (7.24) 69 (7.04) 89 (9.06) 0.184
 Mechanical ventilation 382 (38.98) 424 (43.27) 486 (49.49) <0.001
Primary outcome, n(%)
 30-day mortality 137 (13.98) 170 (17.35) 291 (29.63) <0.001
Secondary outcomes
 In-hospital mortality, n(%) 115 (11.73) 126 (12.86) 228 (23.22) <0.001
 90-day mortality, n(%) 212 (21.63) 263 (26.84) 404 (41.14) <0.001
 365-day mortality, n(%) 347 (35.41) 408 (41.63) 566 (57.64) <0.001
 Hospital LOS, day 10.79 ± 10.92 11.53 ± 9.30 14.66 ± 12.68 <0.001

Note: The data came from patients in MIMIC III database.

Abbreviations: NPAR, ratio of neutrophil to albumin; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; RR, respiratory rate; SpO2, pulse oximetry-derived oxygen saturation; CHF, congestive heart failure; WBC, white blood cell count; RDW, red blood cell distribution width; APTT, activated partial thromboplastin time; INR, international normalized ratio; PT, prothrombin time; SAPSII, simple acute physiology score II; APSIII, acute physiology score III; RRT, renal replacement treatment; LOS, length of stay.